Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. Announces Estimated Price Range for Initial Public Offering
Published in Lab Business Week, August 12th, 2007
Cumberland Pharmaceuticals today filed with the U.S. Securities and Exchange Commission an amendment to its registration statement for the proposed initial public offering of its common stock. The estimated price range for the initial public offering is $14.00 to $16.00 per share. Cumberland proposes to sell 6.25 million shares in the offering, and to grant the underwriters an option to purchase up to an additional 937,500 shares to cover over-allotments, if any. All of the shares of common stock will be offered by Cumberland.
UBS Investment Bank will serve as the sole book-running manager for the offering. Jefferies & Company, Wachovia Securities and Morgan Joseph will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-08-12)
More Articles from Lab Business Week
- Auriga Laboratories, Inc.
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations - Autism
New Model for Autism Suggests Women Carry the Disorder and Explains Age as a Risk Factor - Biochips
Biochips can save lives in Myocardial Infarction patients - Biomedical Engineering
Researchers at Abbott Laboratories target biomedical engineering - Cancer Vaccines
Milford Medical Laboratory Offers No-False-Positive DNA-sequencing Human Papillomavirus (HPV), Chlamydia and Gonococcus Tests - Clinical and Laboratory Standards Institute (CLSI)
CLSI Publishes Guideline on Platelet Function Testing by Aggregometry - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
